Form 4: Pulse Biosciences Director Duggan Receives Stock Options

Robert W. Duggan, a director and 10% owner of Pulse Biosciences, Inc., was granted stock options to purchase 36,247 shares of common stock on June 6, 2024.

Summary

• On June 6, 2024, Robert W. Duggan, a director of Pulse Biosciences, Inc., received stock options.
• These options grant him the right to purchase a total of 36,247 shares of common stock at an exercise price of $14.55 per share.
• 20,000 of these shares will vest in equal monthly installments over one year, starting July 6, 2024.
• The remaining 16,247 shares will vest in equal quarterly installments over one year, starting September 5, 2024.
• Vesting is contingent upon Duggan's continued service with the company through each vesting date.
• The options expire on June 6, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which is neither particularly positive nor negative on its own.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard practice in the biotech industry, often used to compensate directors and executives.
• Companies like CRISPR Therapeutics and Intellia Therapeutics also utilize stock options as part of their compensation packages.
• The vesting schedules and exercise prices are generally in line with industry norms for similar-sized companies.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director.
• Employees may see it as a sign of confidence in the company's future.

Key Dates